We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| CVS Group Plc | AQSE:CVSG.GB | Aquis Stock Exchange | Ordinary Share | GB00B2863827 | Ordinary Shares 20p |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -30.00 | -3.51% | 825.00 | 610.00 | 1,040.00 | 835.00 | 812.64 | 835.00 | 1,149 | 16:29:53 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2023 to Jan 2025
TIDMCVSG
RNS Number : 6472U
CVS Group plc
24 November 2023
24 November 2023
CVS Group plc
("CVS" or the "Company")
Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing
CVS Group plc (the "Company") announces that as part of its 2023/2024 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors and the person closely associated (PCA) named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:
Richard Fairman 550 SAYE scheme options Robin Alfonso 550 SAYE scheme options Ben Jacklin 517 SAYE scheme options
Katherine Jacklin (PCA to Ben Jacklin) 550 SAYE scheme options
Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of 1,146 pence per share, representing a 20% discount to the average closing middle market price for the three dealing days prior to 1 November 2023, being the invitation date.
In response to accepted invitations, a total of 558,994 SAYE Scheme options over Ordinary Shares were granted on 24 November 2023, equating to 0.79% of the current issued ordinary share capital. Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2027.
The notification below, made in accordance with the requirements of UK MAR, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison Group Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Hot Features
Premium
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Richard Fairman
--------------------------- ------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Chief Executive Officer
--------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name CVS Group plc
--------------------------- ------------------------------------------
b) LEI 213800J41XDQ2NX48O05
--------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------
a) Description of Options over Ordinary shares of 0.2 pence
the financial instrument, each
type of instrument
Identification GB00B2863827
code
--------------------------- ------------------------------------------
b) Nature of the transaction Grant of Options under the SAYE Scheme.
--------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of 1,146p 550
----------
--------------------------- ------------------------------------------
d) Aggregated information
* Aggregated volume
* Price
--------------------------- ------------------------------------------
e) Date of the transaction 24 November 2023
--------------------------- ------------------------------------------
f) Place of the transaction Off market
--------------------------- ------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Robin Alfonso
--------------------------- ------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Chief Financial Officer
--------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name CVS Group plc
--------------------------- ------------------------------------------
b) LEI 213800J41XDQ2NX48O05
--------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------
a) Description of Options over Ordinary shares of 0.2 pence
the financial instrument, each
type of instrument
Identification GB00B2863827
code
--------------------------- ------------------------------------------
b) Nature of the transaction Grant of Options under the SAYE Scheme.
--------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of 1,146p 550
----------
--------------------------- ------------------------------------------
d) Aggregated information
* Aggregated volume
* Price
--------------------------- ------------------------------------------
e) Date of the transaction 24 November 2023
--------------------------- ------------------------------------------
f) Place of the transaction Off market
--------------------------- ------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Ben Jacklin
--------------------------- ------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Deputy CEO
--------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name CVS Group plc
--------------------------- ------------------------------------------
b) LEI 213800J41XDQ2NX48O05
--------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------
a) Description of Options over Ordinary shares of 0.2 pence
the financial instrument, each
type of instrument
Identification GB00B2863827
code
--------------------------- ------------------------------------------
b) Nature of the transaction Grant of Options under the SAYE Scheme.
--------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of 1,146p 517
----------
--------------------------- ------------------------------------------
d) Aggregated information
* Aggregated volume
* Price
--------------------------- ------------------------------------------
e) Date of the transaction 24 November 2023
--------------------------- ------------------------------------------
f) Place of the transaction Off market
--------------------------- ------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Katherine Jacklin
--------------------------- ------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status PCA to Deputy CEO Ben Jacklin
--------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name CVS Group plc
--------------------------- ------------------------------------------
b) LEI 213800J41XDQ2NX48O05
--------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------
a) Description of Options over Ordinary shares of 0.2 pence
the financial instrument, each
type of instrument
Identification GB00B2863827
code
--------------------------- ------------------------------------------
b) Nature of the transaction Grant of Options under the SAYE Scheme.
--------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of 1,146p 550
----------
--------------------------- ------------------------------------------
d) Aggregated information
* Aggregated volume
* Price
--------------------------- ------------------------------------------
e) Date of the transaction 24 November 2023
--------------------------- ------------------------------------------
f) Place of the transaction Off market
--------------------------- ------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBIBATMTATBTJ
(END) Dow Jones Newswires
November 24, 2023 10:56 ET (15:56 GMT)
1 Year CVS Chart |
1 Month CVS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
